Akses terbuka Jurnal SINTA 1
Increased hs-CRP and Sepsis Influence the Occurrence of Thrombocytopenia in Severe and Critically Ill COVID-19 Patients Receiving Anticoagulants
The Indonesian Biomedical Journal · Vol. 15 No. 1 (2023) · hlm. 77–84
- ISSN
- 2085-3297, 2355-9179
- Terbit
- 2023-02-23
- Penerbit
- Secretariat of The Indonesian Biomedical Journal
- Bahasa
- en
Abstrak
BACKGROUND: Despites its benefits, as one of COVID-19 principal treatments, anticoagulant raises a significant concern regarding the anticoagulant-related thrombocytopenia. However, up to date, there is lack of study examining anticoagulantinduced thrombocytopenia during COVID-19, hence this study was conducted to determine the factors inducing anticoagulant-induced thrombocytopenia in COVID-19 patients.METHODS: An observational cross-sectional study of 106 anticoagulant-treated COVID-19 subjects was conducted. Blood serum was drawn from subjects, then platelets, prothrombin time (PT), activated partial thromboplastin (aPPT), international ratio (INR), D-dimer, ferritin, fibrinogen, and high-sensitivity C-reactive protein (hs-CRP), were measured. For thrombocytopenia risk assessment, the 4T score was calculated. To assess the risk of thrombocytopenia. Statistical analysis using Chi-square and Mann-Whitney U test were performed and followed by multivariate analysis to examine the correlation among the thrombocytopenia risk factors.RESULTS: Significant differences were identified in the length of stay (LOS) (p=0.04), disease severity (p=0.021), sepsis (p=0.006), hs-CRP (p=0.003), and mortality rate (p=0.028) between thrombocytopenia and nonthrombocytopenia groups. A multivariate analysis through linear and logistic regression disclosed an increase in hs-CRP (OR=-0.29; p=0.045) and sepsis (OR=4.32; p=0.03)that precipitate the thrombocytopenia events.CONCLUSION: In severe and critically ill COVID-19 patients, the occurrence of thrombocytopenia was followed by an increase in inflammatory parameters such as D-dimer, fibrinogen, ferritin, hs-CRP and prolonged coagulation. The increase in hs-CRP and sepsis may raise the risk of thrombocytopenia, especially in severe and crtically ill cases of COVID-19.KEYWORDS: COVID-19, anticoagulant, thrombocytopenia, inflammation, infectious disease
Kata kunci
Jaringan kolaborasi para penulis
23 penulis · 101 tautan kepenulisan bersama · 8 lintas organisasi
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
- Universitas Airlangga
- Ollscoil na Gaillimhe – University of Galway
- Afiliasi tidak diketahui
- Organisasi berbeda
- Organisasi sama
- Afiliasi tidak diketahui
- Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
| Rekan penulis | Organisasi | Artikel bersama |
|---|---|---|
| Andi Yasmin Wijaya | Universitas Airlangga | 5 |
| Winona May Hendrata | Universitas Airlangga | 5 |
| Ugroseno Yudho Bintoro | Afiliasi tidak diketahui | 4 |
| Made Putra Sedana | Afiliasi tidak diketahui | 4 |
| Muhammad Noor Muhammad | Afiliasi tidak diketahui | 4 |
| Ario Djatmiko | Afiliasi tidak diketahui | 1 |
| Wiwien Ristanto | Afiliasi tidak diketahui | 1 |
| Lies Mardiyana | Afiliasi tidak diketahui | 1 |
| Sindrawati Sindrawati | Afiliasi tidak diketahui | 1 |
| Fedik Abdul Rantam | Universitas Airlangga | 1 |
| I Ketut Sudiana | Universitas Airlangga | 1 |
| Abdurachman Abdurachman | Universitas Airlangga | 1 |
| Lukman Hakim | Universitas Airlangga | 1 |
| Reny I’tishom | Universitas Airlangga | 1 |
| Steven Sheng Looi | Ollscoil na Gaillimhe – University of Galway | 1 |
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.